On March 15, 2022 Philogen reported its attendance at the 12th Annual World ADC London 2022 (Press release, Philogen, MAR 15, 2022, View Source [SID1234610272]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled "Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in solid lesions".

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled "Modulating the Therapeutic Activity of ADCs & SMDCs With Engineered Cytokine Products".